Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 13 | $20,736,165 |
Sells | 120 | $101,205,948 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 26,452 | 41.94 | 1,109,397 | I |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 83,708 | 14.0689 | 1,177,679 | D |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 34,473 | 39.73 | 1,369,612 | I |
09 Feb 2024 19:47 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 09 Feb 2024 | Sale | 38,739 | 35.3922 | 1,371,058 | D |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 103,885 | 14.0689 | 1,461,548 | D |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 132,016 | 11.6444 | 1,537,247 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 37,180 | 42.77 | 1,590,189 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 37,180 | 42.77 | 1,590,189 | D |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 56,455 | 30.57 | 1,725,829 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 56,455 | 30.57 | 1,725,829 | I |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 54,737 | 32.33 | 1,769,647 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 54,737 | 32.33 | 1,769,647 | D |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 49,591 | 40.62 | 2,014,386 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 28 Oct 2022 | Sale | 71,135 | 30 | 2,134,050 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 28 Oct 2022 | Sale | 71,135 | 30 | 2,134,050 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 03 Nov 2022 | Sale | 75,312 | 30 | 2,259,360 | D |
04 Nov 2022 16:31 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 03 Nov 2022 | Sale | 75,312 | 30 | 2,259,360 | I |
13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Jan 2023 | Sale | 77,128 | 30.29 | 2,336,207 | D |
13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jan 2023 | Sale | 77,128 | 30.29 | 2,336,207 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 31 Oct 2022 | Sale | 94,239 | 30.23 | 2,848,845 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 31 Oct 2022 | Sale | 94,239 | 30.23 | 2,848,845 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 02 Nov 2022 | Sale | 96,581 | 30.02 | 2,899,362 | D |
04 Nov 2022 16:31 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 02 Nov 2022 | Sale | 96,581 | 30.02 | 2,899,362 | I |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 101,189 | 31.44 | 3,181,382 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 101,189 | 31.44 | 3,181,382 | D |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 112,819 | 30.28 | 3,416,159 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 112,819 | 30.28 | 3,416,159 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 108,404 | 42.19 | 4,573,565 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 108,404 | 42.19 | 4,573,565 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 126,066 | 41.94 | 5,287,208 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 126,066 | 41.94 | 5,287,208 | D |
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 233,362 | 26 | 6,067,412 | D |
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 285,046 | 26 | 7,411,196 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)